ACA Cost-Sharing Reductions
Cost-Sharing Reductions (CSRs) are subsidies built into the Affordable Care Act that dramatically lower out-of-pocket costs — deductibles, copays, and coinsurance — for low-income Americans who buy Silver plans on the ACA Marketplace. They're separate from premium tax credits and can be more valuable: a family at 150% of the federal poverty level (~$30,000/year for a family of two in 2026) on a standard Silver plan would normally face a $4,500 deductible, but with CSRs that deductible drops to roughly $75 and the plan covers 94% of costs instead of 70%. You only get CSRs on Silver plans — which creates the "Silver loading" dynamic where Silver plans often have the most favorable overall value for low-income enrollees. CSRs were nearly eliminated in 2017 when the Trump administration stopped reimbursing insurers for them (in a legal dispute over Congressional appropriation), but insurers responded by raising Silver premiums to compensate — ironically increasing premium tax credit subsidies for many enrollees. The Biden administration reversed the payment halt; the legal and policy questions remain contested.
Current Law (2026)
Cost-Sharing Reductions (CSRs) lower out-of-pocket costs (deductibles, copays, coinsurance) for low-income Marketplace enrollees who select Silver plans.
| Income Level | Actuarial Value | Approximate Deductible |
|---|---|---|
| 100-150% FPL | 94% | ~$75 |
| 150-200% FPL | 87% | ~$650 |
| 200-250% FPL | 73% | ~$3,000 |
| Standard Silver | 70% | ~$4,500 |
Legal Authority
- 42 U.S.C. § 18071 — Reduced cost-sharing for individuals enrolling in qualified health plans (CSR payments to insurers, actuarial value increases by income tier)
- ACA Section 1402 — Reduced cost-sharing for eligible enrollees
How It Works
Cost-Sharing Reductions are embedded in Silver plans exclusively — selecting any other metal tier (Bronze, Gold, Platinum) forfeits your CSR entirely, even if your income qualifies. This isn't a technicality; it's deliberate policy design under 42 U.S.C. § 18071 that ties the actuarial value enhancement to the Silver tier. At 100–150% FPL, the difference between a CSR-enhanced Silver plan (~94% actuarial value, ~$75 deductible) and a Bronze plan (~60% actuarial value, $7,000–9,000 deductible) can exceed $5,000–10,000 in out-of-pocket exposure if you actually need care. For income-eligible enrollees, Silver is almost always the right metal choice.
The federal funding structure for CSRs has been contested since 2017, when the Trump administration halted direct payments to insurers — arguing Congress never appropriated funds specifically for CSR reimbursement. Insurers adapted with "silver loading": building the lost reimbursement into Silver plan premiums. Because the Premium Tax Credit benchmark is calculated against the Silver plan cost in each market, inflated Silver premiums automatically translate into larger PTCs. This inadvertently benefited many mid-income enrollees who could apply their larger PTC to non-Silver plans — getting $0-premium Bronze or low-cost Gold coverage in many markets. CSR-eligible enrollees (100–250% FPL) still benefit most from staying in Silver to capture the actuarial value enhancement. Silver loading is now a permanent structural feature of Marketplace pricing, not a temporary disruption.
Eligibility for CSRs is verified at enrollment using prior-year tax return data and projected household income. Individuals near the Medicaid eligibility threshold (typically 138% FPL in Medicaid expansion states) may qualify for Medicaid rather than CSRs — Medicaid is generally more comprehensive and lower-cost than even a CSR-enhanced Silver plan for this income range. In the 10+ states that have not expanded Medicaid, individuals below 100% FPL fall into the "coverage gap" — ineligible for both Medicaid and Marketplace subsidies. See Medicaid Income Limits for state-specific eligibility thresholds.
How It Affects You
If you earn 100-200% FPL and are enrolling through the Marketplace: Choosing Silver is almost always the right call — this is one of the most consequential plan-selection decisions you can make. A CSR-enhanced Silver plan at 100-150% FPL brings your deductible down to roughly $75 and covers 94% of costs — the same protection level as a Platinum plan, often at a fraction of the cost. Choosing Bronze at this income level means forfeiting the CSR entirely: you'd pay a lower monthly premium but face deductibles of $7,000-$9,000 if you actually need care. You lose CSRs the moment you choose any non-Silver plan. Enroll at healthcare.gov (or your state exchange — find it at healthcare.gov/marketplace-in-your-state) during Open Enrollment (November 1 – January 15) or during a Special Enrollment Period. Call 1-800-318-2596 if you need help comparing plans; navigators and assisters are available free at localhelp.healthcare.gov. Note: the enhanced premium tax credits that reduced premiums in 2021-2025 expired at year-end 2025, so 2026 net premiums are higher than 2025 for many enrollees — recalculate your budget rather than assuming last year's premium still applies.
If you earn 200-250% FPL: You still get a meaningful CSR — your deductible drops to roughly $650-$3,000 vs. $4,500 standard Silver — but the silver loading effect means you need to compare Silver against Gold plan net premiums carefully. Silver loading (insurers built the lost federal CSR payment into Silver premiums since 2017) inflated the Silver benchmark used to calculate your Premium Tax Credit. At 200-250% FPL in many markets, the Gold plan after your PTC costs the same as or less than Silver, but with a lower deductible and better cost-sharing. On healthcare.gov or your state exchange, select the plan comparison view and look at the after-credit monthly premium side-by-side for Silver and Gold. Don't assume the metal tier label determines value — run the actual numbers for your county.
If you earn above 250% FPL: No CSR available. Focus plan selection on two factors: (1) whether your specific doctors, specialists, and prescriptions are in-network and on formulary — look up your medications at each plan's drug formulary tool on healthcare.gov before enrolling; (2) your realistic annual healthcare usage to weigh premium vs. deductible. With the 2025 enhanced PTCs expired, $0-premium Bronze plans that were available in many markets in 2022-2025 may no longer be available at higher income levels in 2026 — check current plan pricing rather than relying on prior-year experience.
If you're a navigator, assister, or broker helping low-income enrollees: The CSR benefit at 100-150% FPL is often worth more per year than the premium tax credit. A client who forgoes CSR by choosing Bronze over Silver is effectively paying $5,000-$10,000 more in expected out-of-pocket costs to save $50-$100/month in premium — a bad trade at this income level. When helping clients near 138% FPL in Medicaid expansion states, verify whether they qualify for Medicaid (generally cheaper and more comprehensive) before recommending any Marketplace plan. localhelp.healthcare.gov lists trained navigators and enrollment assisters by zip code.
Implementing Regulations
- 45 CFR Part 156 — QHP standards (§§ 156.215, 156.440, 156.460 — advance payments of premium tax credits and cost-sharing reduction standards, plans eligible for CSRs, enrollee premium reduction calculations)
- 45 CFR Part 155 — Exchange standards (§ 155.340 — administration of advance payments and cost-sharing reductions)
- 45 CFR Part 800 — Multi-State Plan Program (§ 800.106 — cost-sharing limits and advance payments)
- 42 CFR Part 447 — Medicaid payment (§§ 447.50–447.56 — premiums and cost-sharing basis, cost-sharing amounts, drug cost-sharing)
- 42 CFR Part 457 — CHIP (§§ 457.224, 457.515, 457.520 — FFP conditions for cost sharing, state plan cost-sharing requirements, well-child care cost sharing)
- 42 CFR Part 438 — Medicaid managed care (§ 438.108 — cost sharing)
Pending Legislation
- HR 6171 — ACA Copay CAP Act of 2025: cap annual prescription drug cost-sharing at $2,000 for self-only plans and $4,000 for other coverage starting plan years beginning Jan 1, 2027, indexed thereafter. Status: Introduced.
- CSR funding restoration: Proposals to resume federal CSR payments and end silver loading.
Recent Developments
- Silver loading remains in effect — a structural feature, not a bug: Trump's 2017 decision to halt federal CSR payments to insurers has never been reversed, despite several attempts. Insurers have adapted by permanently building the cost into Silver premiums — a practice known as "silver loading." This creates a structural benefit: because Premium Tax Credits are calculated against the Silver benchmark, higher Silver premiums mean larger PTCs, allowing many enrollees to get $0-premium Bronze plans. Silver loading is now an expected feature of Marketplace pricing, not a temporary disruption.
- Enhanced subsidies expiration in 2026 compounds CSR decision-making: The enhanced PTCs enacted under the American Rescue Plan (2021) and extended through 2025 expired at year-end 2025. This means the PTC amounts used to calculate affordability in 2026 are lower than 2025 — for some enrollees, this narrows the PTC benefit to the point where even silver-loaded coverage becomes unaffordable. CSR-eligible enrollees (100-250% FPL) are partially insulated because their cost-sharing benefit is independent of PTC generosity, but those near the 250% FPL line face the cliff in both dimensions simultaneously.
- Medicaid expansion gap affects CSR eligibility at bottom of income scale: In states that did not expand Medicaid, individuals below 100% FPL are ineligible for both Medicaid and PTCs/CSRs (the "coverage gap"). As of 2026, roughly 10 states still have not adopted Medicaid expansion. Individuals between 100-138% FPL in expansion states qualify for Medicaid rather than Marketplace CSRs — a distinction that matters at enrollment because Medicaid covers more broadly at lower cost.
- ACA copay cap legislation pending: HR 6171 (ACA Copay CAP Act of 2025) would cap annual prescription drug cost-sharing at $2,000 for individual plans. If enacted, this would effectively establish a federal CSR-equivalent floor for drug costs across all plan tiers, reducing the gap between CSR-enhanced Silver and higher-tier plans for enrollees whose costs are driven primarily by medications. The bill has not advanced as of early 2026.